glp-1 and muscle mass loss matters: the effects of medically induced weight on skeletal muscle Weight loss with GLP-1 medicines

The only head-to-head trial (SURPASS-2) compared tirzepatide to semaglutide 1 mg for diabetes and found tirzepatide better for both HbA1c and weight

Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: Insights from surpass clinical program

Physiol Rev 2016;96:151-176

Variations in dosage and formulation may occur, and side effects like nausea or gastrointestinal discomfort are possible

unclear human risk) Contraindications: Personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 Severe gastrointestinal disease GLP-2 Safety Profile Common Side Effects: Injection site reactions Headache Abdominal pain or distension Nausea Serious but Rare: Intestinal obstruction Gallbladder and bile duct issues Fluid overload Contraindications: Active gastrointestinal malignancy Known hypersensitivity to the medication General Safety Recommendations Always use pharmaceutical-grade peptides from reputable sources Start with lower doses and increase gradually Monitor for side effects closely Stay well-hydrated Maintain regular medical check-ups Report any concerning symptoms immediately Find the GLP right for you While GLP-1, GLP-2, and GLP-3 all originate from the same proglucagon precursor, they serve vastly different functions in your body: GLP-1 is your metabolic master regulator, controlling blood sugar, appetite, and weight while protecting your heart and potentially your brain